Stool antigen tests for helicobacter pylori infection: a review of clinical and cost-effectiveness and guidelines

Record ID 32016000147
Authors' recommendations: Certain commercially available stool antigen tests with high test performance (sensitivity and specificity) provide reliable results in the diagnosis of H. pylori infection and in follow-up testing after eradication therapy. The use of a stool antigen test-and-treat strategy in relieving symptoms of dyspepsia or reducing the burden of gastric cancer and peptic ulceration was cost-effective. Guidelines recommend a laboratory-based validated monoclonal stool test for test-and-treat strategies and for follow-up testing after eradication therapy.
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Rapid Review
Country: Canada
MeSH Terms
  • Feces
  • Helicobacter pylori
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.